Polycythemia Vera and Acute Leukemia

  1. LEO T. NEU, M.D., F.A.C.P.;
  2. MARC A. SHUMAN, M.D.; and
  3. ELMER B. BROWN, M.D.
  1. Smith-Glynn-Callaway Clinic
    1211 South Glenstone
    Springfield, Missouri 65804
  2. Division of Hematology
    Washington University School of Medicine
    660 South Euclid

    St. Louis, Missouri 63110

    Excerpt

    The transformation of polycythemia vera into acute leukemia is a well-documented phenomenon and is reported to occur as a terminal complication in approximately 15% of polycythemia vera patients (1, 2). The role of 32P-therapy in the cause of leukemia in this setting is controversial. We have recently treated a patient with polycythemia vera who developed acute myelomonocytic leukemia. Subsequent to remission induction with chemotherapy, she developed polycythemia vera once again before eventually dying of acute leukemia. To our knowledge, this is the first recorded instance of this sequence of events.

    The patient, a 67-year-old woman, was found to be polycythemic

    « Previous | Next Article »Table of Contents